{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:14:41Z","timestamp":1790745281004,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T00:00:00Z","timestamp":1452470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s13277-015-4660-z","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T03:15:39Z","timestamp":1452482139000},"page":"8869-8877","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The tumor suppressive role of RASSF1A in osteosarcoma through the Wnt signaling pathway"],"prefix":"10.1007","volume":"37","author":[{"given":"Wei-Guo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Shen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Song","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Fang","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,11]]},"reference":[{"key":"4660_CR1","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1158\/1078-0432.CCR-05-0165","volume":"11","author":"OS Bruland","year":"2005","unstructured":"Bruland OS, Hoifodt H, Saeter G, Smeland S, Fodstad O. Hematogenous micrometastases in osteosarcoma patients. Clin Cancer Res. 2005;11:4666\u201373.","journal-title":"Clin Cancer Res"},{"key":"4660_CR2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/00001622-199807000-00009","volume":"10","author":"BP Himelstein","year":"1998","unstructured":"Himelstein BP. Osteosarcoma and other bone cancers. Curr Opin Oncol. 1998;10:326\u201333.","journal-title":"Curr Opin Oncol"},{"key":"4660_CR3","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1002\/cncr.21937","volume":"106","author":"G Bacci","year":"2006","unstructured":"Bacci G, Longhi A, Cesari M, Versari M, Bertoni F. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients. Cancer. 2006;106:2701\u20136.","journal-title":"Cancer"},{"key":"4660_CR4","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/annonc\/mdp502","volume":"21","author":"P Picci","year":"2010","unstructured":"Picci P, Mercuri M, Ferrari S, et al. Survival in high-grade osteosarcoma: improvement over 21 years at a single institution. Ann Oncol. 2010;21:1366\u201373.","journal-title":"Ann Oncol"},{"key":"4660_CR5","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s10541-005-0151-y","volume":"70","author":"GP Pfeifer","year":"2005","unstructured":"Pfeifer GP, Dammann R. Methylation of the tumor suppressor gene RASSF1A in human tumors. Biochemistry (Mosc). 2005;70:576\u201383.","journal-title":"Biochemistry (Mosc)"},{"key":"4660_CR6","first-page":"645","volume":"20","author":"R Dammann","year":"2005","unstructured":"Dammann R, Schagdarsurengin U, Seidel C, et al. The tumor suppressor RASSF1A in human carcinogenesis: an update. Histol Histopathol. 2005;20:645\u201363.","journal-title":"Histol Histopathol"},{"key":"4660_CR7","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/sj.onc.1204175","volume":"20","author":"A Agathanggelou","year":"2001","unstructured":"Agathanggelou A, Honorio S, Macartney DP, et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene. 2001;20:1509\u201318.","journal-title":"Oncogene"},{"key":"4660_CR8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/1477-3163.93000","volume":"11","author":"KS Amin","year":"2012","unstructured":"Amin KS, Banerjee PP. The cellular functions of RASSF1A and its inactivation in prostate cancer. J Carcinog. 2012;11:3.","journal-title":"J Carcinog"},{"key":"4660_CR9","doi-asserted-by":"crossref","unstructured":"9. Zhou PH, Zheng JB, Wei GB, et al. Lentivirus-mediated RASSF1A expression suppresses aggressive phenotypes of gastric cancer cells in vitro and in vivo. Gene Ther 2015.","DOI":"10.1038\/gt.2015.49"},{"key":"4660_CR10","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3892\/ijmm.2014.1671","volume":"33","author":"L Fu","year":"2014","unstructured":"Fu L, Zhang S. RASSF1A promotes apoptosis and suppresses the proliferation of ovarian cancer cells. Int J Mol Med. 2014;33:1153\u201360.","journal-title":"Int J Mol Med"},{"key":"4660_CR11","doi-asserted-by":"crossref","first-page":"6253","DOI":"10.1074\/jbc.M110.178210","volume":"286","author":"C Guo","year":"2011","unstructured":"Guo C, Zhang X, Pfeifer GP. The tumor suppressor RASSF1A prevents dephosphorylation of the mammalian STE20-like kinases MST1 and MST2. J Biol Chem. 2011;286:6253\u201361.","journal-title":"J Biol Chem"},{"key":"4660_CR12","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1158\/0008-5472.CAN-05-2951","volume":"66","author":"HJ Oh","year":"2006","unstructured":"Oh HJ, Lee KK, Song SJ, et al. Role of the tumor suppressor RASSF1A in Mst1-mediated apoptosis. Cancer Res. 2006;66:2562\u20139.","journal-title":"Cancer Res"},{"key":"4660_CR13","first-page":"897","volume":"10","author":"S Lim","year":"2003","unstructured":"Lim S, Yang MH, Park JH, et al. Inactivation of the RASSF1A in osteosarcoma. Oncol Rep. 2003;10:897\u2013901.","journal-title":"Oncol Rep"},{"key":"4660_CR14","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1038\/sj.onc.1205446","volume":"21","author":"K Harada","year":"2002","unstructured":"Harada K, Toyooka S, Maitra A, et al. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines. Oncogene. 2002;21:4345\u20139.","journal-title":"Oncogene"},{"key":"4660_CR15","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2741\/4187","volume":"18","author":"C Li","year":"2013","unstructured":"Li C, Shi X, Zhou G, et al. The canonical Wnt-beta-catenin pathway in development and chemotherapy of osteosarcoma. Front Biosci (Landmark Ed). 2013;18:1384\u201391.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"4660_CR16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","volume":"17","author":"BT MacDonald","year":"2009","unstructured":"MacDonald BT, Tamai K, He X. Wnt\/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17:9\u201326.","journal-title":"Dev Cell"},{"key":"4660_CR17","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1158\/0008-5472.CAN-03-1952","volume":"64","author":"BH Hoang","year":"2004","unstructured":"Hoang BH, Kubo T, Healey JH, et al. Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway. Cancer Res. 2004;64:2734\u20139.","journal-title":"Cancer Res"},{"key":"4660_CR18","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.3892\/or.2013.2658","volume":"30","author":"Y Liu","year":"2013","unstructured":"Liu Y, Wang W, Xu J, et al. Dihydroartemisinin inhibits tumor growth of human osteosarcoma cells by suppressing Wnt\/beta-catenin signaling. Oncol Rep. 2013;30:1723\u201330.","journal-title":"Oncol Rep"},{"key":"4660_CR19","first-page":"147541","volume":"2013","author":"CH Lin","year":"2013","unstructured":"Lin CH, Guo Y, Ghaffar S, et al. Dkk-3, a secreted wnt antagonist, suppresses tumorigenic potential and pulmonary metastasis in osteosarcoma. Sarcoma. 2013;2013:147541.","journal-title":"Sarcoma"},{"key":"4660_CR20","doi-asserted-by":"crossref","first-page":"5917","DOI":"10.7314\/APJCP.2014.15.14.5917","volume":"15","author":"L Feng","year":"2014","unstructured":"Feng L, Li J, Yan LD, Tang J. RASSF1A suppresses proliferation of cervical cancer cells. Asian Pac J Cancer Prev. 2014;15:5917\u201320.","journal-title":"Asian Pac J Cancer Prev"},{"key":"4660_CR21","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1158\/0008-5472.CAN-05-0247","volume":"65","author":"A Dallol","year":"2005","unstructured":"Dallol A, Agathanggelou A, Tommasi S, et al. Involvement of the RASSF1A tumor suppressor gene in controlling cell migration. Cancer Res. 2005;65:7653\u20139.","journal-title":"Cancer Res"},{"key":"4660_CR22","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1128\/MCB.22.12.4309-4318.2002","volume":"22","author":"L Shivakumar","year":"2002","unstructured":"Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol. 2002;22:4309\u201318.","journal-title":"Mol Cell Biol"},{"key":"4660_CR23","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1158\/0008-5472.CAN-11-3343","volume":"72","author":"L Weyden van der","year":"2012","unstructured":"van der Weyden L, Papaspyropoulos A, Poulogiannis G, et al. Loss of RASSF1A synergizes with deregulated RUNX2 signaling in tumorigenesis. Cancer Res. 2012;72:3817\u201327.","journal-title":"Cancer Res"},{"key":"4660_CR24","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1002\/jcp.22568","volume":"226","author":"M Yi","year":"2011","unstructured":"Yi M, Yang J, Chen X, et al. RASSF1A suppresses melanoma development by modulating apoptosis and cell-cycle progression. J Cell Physiol. 2011;226:2360\u20139.","journal-title":"J Cell Physiol"},{"key":"4660_CR25","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1073\/pnas.131216298","volume":"98","author":"K Dreijerink","year":"2001","unstructured":"Dreijerink K, Braga E, Kuzmin I, et al. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc Natl Acad Sci U S A. 2001;98:7504\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4660_CR26","first-page":"3498","volume":"62","author":"I Kuzmin","year":"2002","unstructured":"Kuzmin I, Gillespie JW, Protopopov A, et al. The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells. Cancer Res. 2002;62:3498\u2013502.","journal-title":"Cancer Res"},{"key":"4660_CR27","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1158\/0008-5472.CAN-08-1377","volume":"69","author":"S Thaler","year":"2009","unstructured":"Thaler S, Hahnel PS, Schad A, Dammann R, Schuler M. RASSF1A mediates p21Cip1\/Waf1-dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of Akt. Cancer Res. 2009;69:1748\u201357.","journal-title":"Cancer Res"},{"key":"4660_CR28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/jcb.24708","volume":"115","author":"Y Cai","year":"2014","unstructured":"Cai Y, Cai T, Chen Y. Wnt pathway in osteosarcoma, from oncogenic to therapeutic. J Cell Biochem. 2014;115:625\u201331.","journal-title":"J Cell Biochem"},{"key":"4660_CR29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc3419","volume":"13","author":"JN Anastas","year":"2013","unstructured":"Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer. 2013;13:11\u201326.","journal-title":"Nat Rev Cancer"},{"key":"4660_CR30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/leu.2013.184","volume":"28","author":"JA McCubrey","year":"2014","unstructured":"McCubrey JA, Steelman LS, Bertrand FE, et al. Multifaceted roles of GSK-3 and Wnt\/\u03b2-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention. Leukemia. 2014;28:15\u201333.","journal-title":"Leukemia"},{"key":"4660_CR31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/alzrt265","volume":"6","author":"Y Kitagishi","year":"2014","unstructured":"Kitagishi Y, Nakanishi A, Ogura Y, Matsuda S. Dietary regulation of PI3K\/AKT\/GSK-3\u03b2 pathway in Alzheimer\u2019s disease. Alzheimers Res Ther. 2014;6:35.","journal-title":"Alzheimers Res Ther"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4660-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-4660-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4660-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T10:31:02Z","timestamp":1567506662000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-4660-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,11]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["4660"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-4660-z","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,11]]}}}